Audiologists in Baraboo, WI Accepting Medicare

3 Audiologists found. Showing 1 - 3

St Clare Hospital And Health Audiologist Medicare: Not Enrolled in Medicare Practice Location: 707 14th St, Baraboo, WI 53913 Phone: 608-356-1400

Bethany C Frostman Audiologist Medicare: Not Enrolled in Medicare Practice Location: 707 14th St, Baraboo, WI 53913 Phone: 608-356-1400

Alison Allstadt Audiologist Medicare: Not Enrolled in Medicare Practice Location: 707 14th St, Baraboo, WI 53913 Phone: 608-356-1400

News Archive

Physician Therapeutics publishes results from Sentra PM clinical trial

Physician Therapeutics, Inc., a division of Targeted Medical Pharma, Inc., a specialty pharmaceutical company that manufactures and distributes specialty pharmaceuticals to physicians, pharmacies and skilled nursing facilities, published results from a clinical trial of the proprietary medical food Sentra PM.

SMISS launches online series of CME-accredited education modules for spine surgeons

Since its founding in 2007, the Society for Minimally Invasive Spine Surgery (SMISS) has become the pre-eminent professional society for MIS surgeons. On March 1, 2010, the organization's educational activities expanded dramatically with the launch of SMISS Highlights, an online series of CME-accredited education modules that are free of charge for spine surgeons.

Unexpected discovery paves way for new insights in regulation of bacterial virulence

Chemists and molecular biologists have made an unexpected discovery in infection biology. The researchers can now show that two proteins that bind to one another slow down a chemical reaction central to the course of the disease in the bacteria Yersinia pseudotuberculosis.

FDA grants orphan drug designation for ICT-107

ImmunoCellular Therapeutics announced today that the U.S. Food and Drug Administration has granted orphan drug designation for ICT-107, the company's dendritic cell-based cancer vaccine candidate which targets glioblastoma multiforme. As a result of the orphan drug status, ImmunoCellular will be eligible to receive a number of benefits, including access to grant funding for clinical trials, tax credits, accelerated FDA approval and allowance for marketing exclusivity after drug approval for a period of up to seven years.

Read more Medical News

› Verified 3 days ago